{
    "id": 25766,
    "fullName": "MERTK positive",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "MERTK positive indicates the presence of the MERTK gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 10461,
        "geneSymbol": "MERTK",
        "terms": [
            "MERTK",
            "c-Eyk",
            "c-mer",
            "MER",
            "RP38",
            "Tyro12"
        ]
    },
    "variant": "positive",
    "createDate": "11/28/2016",
    "updateDate": "07/06/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 10337,
            "approvalStatus": "Preclinical - Pdx & cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, UNC2025 inhibited Mertk signaling, resulted in apoptosis and growth inhibition of patient-derived acute lymphocytic leukemia cells in culture, and prolonged survival in patient-derived xenograft models (PMID: 27649555).",
            "molecularProfile": {
                "id": 26845,
                "profileName": "MERTK positive"
            },
            "therapy": {
                "id": 3291,
                "therapyName": "UNC2025",
                "synonyms": null
            },
            "indication": {
                "id": 9119,
                "name": "acute myeloid leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 8318,
                    "pubMedId": 27649555,
                    "title": "UNC2025, a MERTK Small-Molecule Inhibitor, Is Therapeutically Effective Alone and in Combination with Methotrexate in Leukemia Models.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27649555"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 16664,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, UNC1062 inhibited Mertk phosphorylation and downstream signaling, resulted in growth inhibition of acute myeloid leukemia cell lines in culture (PMID: 29277773).",
            "molecularProfile": {
                "id": 26845,
                "profileName": "MERTK positive"
            },
            "therapy": {
                "id": 8127,
                "therapyName": "UNC1062",
                "synonyms": null
            },
            "indication": {
                "id": 9119,
                "name": "acute myeloid leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 14709,
                    "pubMedId": 29277773,
                    "title": "Effects of MERTK Inhibitors UNC569 and UNC1062 on the Growth of Acute Myeloid Leukaemia Cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29277773"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 16666,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, UNC1666 inhibited Mertk phosphorylation and downstream signaling, induced apoptosis of acute myeloid leukemia cell lines in culture (PMID: 25762638).",
            "molecularProfile": {
                "id": 26845,
                "profileName": "MERTK positive"
            },
            "therapy": {
                "id": 8128,
                "therapyName": "UNC1666",
                "synonyms": null
            },
            "indication": {
                "id": 9119,
                "name": "acute myeloid leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 14710,
                    "pubMedId": 25762638,
                    "title": "Efficacy of a Mer and Flt3 tyrosine kinase small molecule inhibitor, UNC1666, in acute myeloid leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25762638"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 10338,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, combination of UNC2025 and Methotrexate resulted in improved tumor suppression and survival compared to single agent treatment in cell line xenograft models of acute lymphocytic leukemia (PMID: 27649555).",
            "molecularProfile": {
                "id": 26845,
                "profileName": "MERTK positive"
            },
            "therapy": {
                "id": 5474,
                "therapyName": "Methotrexate + UNC2025",
                "synonyms": null
            },
            "indication": {
                "id": 9952,
                "name": "acute lymphoblastic leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 8318,
                    "pubMedId": 27649555,
                    "title": "UNC2025, a MERTK Small-Molecule Inhibitor, Is Therapeutically Effective Alone and in Combination with Methotrexate in Leukemia Models.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27649555"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 16663,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, UNC569 inhibited Mertk phosphorylation and downstream signaling, resulted in growth inhibition of acute myeloid leukemia cell lines in culture (PMID: 29277773).",
            "molecularProfile": {
                "id": 26845,
                "profileName": "MERTK positive"
            },
            "therapy": {
                "id": 8126,
                "therapyName": "UNC569",
                "synonyms": null
            },
            "indication": {
                "id": 9119,
                "name": "acute myeloid leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 14709,
                    "pubMedId": 29277773,
                    "title": "Effects of MERTK Inhibitors UNC569 and UNC1062 on the Growth of Acute Myeloid Leukaemia Cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29277773"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 17389,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, RGX-019 treatment induced Mertk internalization and degradation in tumor cell lines, leading to inhibition of colony formation in culture (AACR Annual Meeting 2019, Abstract LB-277).",
            "molecularProfile": {
                "id": 26845,
                "profileName": "MERTK positive"
            },
            "therapy": {
                "id": 8482,
                "therapyName": "RGX-019",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 15411,
                    "pubMedId": null,
                    "title": "Characterization of the anti-cancer and immunologic activity of RGX-019, a novel pre-clinical stage humanized monoclonal antibody targeting the MERTK receptor",
                    "url": "https://www.abstractsonline.com/pp8/#!/6812/presentation/9185"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 10336,
            "approvalStatus": "Preclinical - Patient cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, UNC2025 inhibited Mertk signaling, resulted in apoptosis and growth inhibition of patient-derived acute lymphocytic leukemia cells in culture, and prolonged survival in orthotopic murine xenograft models (PMID: 27649555).",
            "molecularProfile": {
                "id": 26845,
                "profileName": "MERTK positive"
            },
            "therapy": {
                "id": 3291,
                "therapyName": "UNC2025",
                "synonyms": null
            },
            "indication": {
                "id": 9952,
                "name": "acute lymphoblastic leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 8318,
                    "pubMedId": 27649555,
                    "title": "UNC2025, a MERTK Small-Molecule Inhibitor, Is Therapeutically Effective Alone and in Combination with Methotrexate in Leukemia Models.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27649555"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 9428,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, MRX-2843 inhibited Mertk signaling, resulted in growth inhibition in FLT3 wild-type acute myeloid leukemia cells in culture and in cell line xenograft models, and prolonged survival in patient-derived xenograft models (PMID: 27158668).",
            "molecularProfile": {
                "id": 26846,
                "profileName": "FLT3 wild-type MERTK pos"
            },
            "therapy": {
                "id": 5016,
                "therapyName": "MRX-2843",
                "synonyms": null
            },
            "indication": {
                "id": 9119,
                "name": "acute myeloid leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 7187,
                    "pubMedId": 27158668,
                    "title": "The MERTK/FLT3 inhibitor MRX-2843 overcomes resistance-conferring FLT3 mutations in acute myeloid leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27158668"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 16670,
            "approvalStatus": "Preclinical - Patient cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, UNC1666 inhibited Mertk and FLT3 phosphorylation and downstream signaling, induced apoptosis of patient-derived acute myeloid leukemia cell lines harboring FLT3 exon 14 insertions (ITD) in culture (PMID: 25762638).",
            "molecularProfile": {
                "id": 31746,
                "profileName": "FLT3 exon 14 ins MERTK pos"
            },
            "therapy": {
                "id": 8128,
                "therapyName": "UNC1666",
                "synonyms": null
            },
            "indication": {
                "id": 9119,
                "name": "acute myeloid leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 14710,
                    "pubMedId": 25762638,
                    "title": "Efficacy of a Mer and Flt3 tyrosine kinase small molecule inhibitor, UNC1666, in acute myeloid leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25762638"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 26845,
            "profileName": "MERTK positive",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 26846,
            "profileName": "FLT3 wild-type MERTK pos",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 31746,
            "profileName": "FLT3 exon 14 ins MERTK pos",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}